Since glycation can lead to the onset of diabetic complications due to chronic
hyperglycemia, several indigenous Artemisia species were evaluated as potential inhibitors …

The development of AGE inhibitors is considered to have therapeutic potential in patients
with diabetes diseases. The aim of the present study was investigate the effect of methanolic …

The development of AGE inhibitors is considered to have therapeutic potential in patients
with diabetes diseases. The aim of the present study was investigate the effect of methanolic …

Advanced glycation end products (AGEs) are major factors responsible for the complication
of diabetes. The present study was carried out to investigate the inhibitory activities on …

Published data suggest that dietary-derived phenolics exert beneficial effects against
hyperglycemia-mediated diseases, such as diabetes, through inhibiting the formation of …

The pathogenesis of diabetic vascular complications involves the formation of advanced
glycation end-products (AGEs). AGEs accumulate slowly in the body with age and more …

Seven phenolic compounds, caffeic acid (1), 4-hydroxybenzoic acid (2), 4-methoxybenzoic
acid (3), protocatechuic acid (4), eugenol O-β-D-glucopyranoside (5), 3, 6-di-O …

Advanced glycation end products (AGEs) have been postulated to play a central role in the
development of diabetic complications. A variety of different agents that inhibit AGEs have …

In an ongoing project directed toward the discovery of novel treatments for diabetic
complications from traditional herbal medicines, fifteen compounds, apigenin (1), apigenin-7 …

Advanced glycation end products (AGEs) has been shown to play an important role in the
development of the diabetic complications. The AGEs inhibitors or cross-link breakers …